Agape ATP Corporation (NASDAQ:ATPC – Get Free Report) saw a significant decline in short interest in the month of December. As of December 31st, there was short interest totaling 1,520,541 shares, a decline of 61.1% from the December 15th total of 3,904,055 shares. Currently, 3.4% of the company’s shares are short sold. Based on an average daily volume of 51,263,248 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 51,263,248 shares, the short-interest ratio is presently 0.0 days. Currently, 3.4% of the company’s shares are short sold.
Agape ATP Stock Performance
Agape ATP stock opened at $0.07 on Thursday. The firm has a market cap of $3.50 million, a price-to-earnings ratio of -0.24 and a beta of -0.40. Agape ATP has a 52-week low of $0.05 and a 52-week high of $2.57. The firm has a 50 day moving average price of $0.67 and a two-hundred day moving average price of $1.08.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Agape ATP in a report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Agape ATP presently has a consensus rating of “Sell”.
Hedge Funds Weigh In On Agape ATP
An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC boosted its position in Agape ATP Corporation (NASDAQ:ATPC – Free Report) by 95.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 65,130 shares of the company’s stock after acquiring an additional 31,849 shares during the period. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. 0.01% of the stock is owned by institutional investors.
About Agape ATP
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Featured Stories
- Five stocks we like better than Agape ATP
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
